-
Forward Look
A Report Card on Active SurveillanceMany men with untreated prostate cancer are not getting proper follow-up.
by Heather Stringer
-
Forward Look
Fine-Tuning Treatments for Triple-Negative Breast CancerStudies aim to identify best available treatments and find new ones.
by Cameron Walker
-
Healthy Habits
Less StressCognitive-behavioral stress management may help women with breast cancer.
by Brenda Conaway
-
Forward Look
Aspirin Recommended to Reduce Colorectal Cancer RiskTask force formally recognizes the benefits, with caveats.
by Yasmine Iqbal
-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
-
Forward Look
Melanoma Risk Increased in Some Lymphoma SurvivorsStudy pinpoints group that may benefit from close surveillance.
by Sharon Reynolds
-
Forward Look
Uterine Cancer Rates on the RiseStudy finds deaths are highest among African-American women.
by Brenda Conaway
-
Forward Look
Cancer Immunotherapies Continue to Make HeadwayDrugs that harness the power of the immune system gain new approvals.
by Alexandra Goho
-
From the Editor-in-Chief
Early-Stage Prostate Cancer: To Treat or Not To TreatStrategies for prostate cancer screening and surveillance are still being refined.
by William G. Nelson, MD, PhD
-
Yesterday & Today
A Storied LifeLiterary realist John Updike used the scaffold of his own life, including his lung cancer diagnosis, to explore the shared experiences of our time.
by Sue Rochman
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
